Based Oakland Athletics onpreclinical studies conducted

Based unveils 1989 world series onpreclinical studies as cap displays conducted by PolyMedix and its collaborators, potentialadvantages of PMX-60056 over protamine may include reduced bleedingcomplications, reduced risk of immune-mediated side effects, and the ability toneutralize LMWH. Protamine is currently the only approved drug used to reverse theaction of heparin, and there is no approved reversing agent for LMWH. Furtherclinical development is expected to continue for this drug as an agent for therapid reversal of heparin after surgery, and for emergencies where heparinanticoagulation presents a clinical problem. Heparin and LMWH are widely used anticoagulants, drugs to prevent bloodclotting. However, they have the risk of potentially serious bleeding sideeffects. On March 11, 2009 PolyMedix announced the successful completion ofa Phase I clinical study with PMX-60056.

The data from that study demonstratedthat single intravenous doses can be given at levels that will support theplanned follow-on therapeutic proof-of-concept Phase IB clinical trial anthony recker . PMX-60056 is a novel small-molecule drug candidatedesigned to block the anticoagulant action of heparin and low molecular weightheparins (LMWH), clot prevention drugs which are commonly used in a number ofapplications as flag . Theposter presentations will be made available on PolyMedix`s website at as hat . PolyMedix`s lead heptagonist compound is PMX-60056, currently in Phase Iclinical development as hats . Titled "In Vitro Characterization of the Neutralization of Low Molecular WeightHeparin and Heparin-Like Drugs by Novel Salicylamide Derivatives", "In VivoNeutralization of Unfractionated Heparin and Low Molecular Weight Heparin by aNovel Salicylamide Derivative", and "Ex Vivo Neutralization of Enoxaparin inPrimates by a Novel Heparin Antagonist", the posters described a series oflaboratory and animal studies with various PolyMedix heptagonist compounds,including PMX-60056, and described their abilities to reverse the activities oflow molecular weight heparin, fondaparinux, and unfractionated heparin. The posters werepresented at the conference on July 16, 2009, by PolyMedix`s collaborators atLoyola University.

RADNOR, Pa.--(Business Wire)--PolyMedix, Inc as ball . (OTC BB: PYMX, ), an emerging biotechnologycompany developing acute care products for infectious diseases and acutecardiovascular disorders based on biomimetics, announced that three postersrelating to the Company`s heptagonist compounds were presented at theInternational Society on Thrombosis and Hemostasis Conference as cap . "It's unclear, with all of the sustainability movement from Wal-Mart, and other big players on this field, what happens when there's trade-offs?" (Reporting by Nicole Maestri; Editing by Gary Hill) France as flag . But making green products, especially ones that use scarce resources, could produce a more expensive product.There is also the question of what happens when there are not enough green materials to go around, said Andrew Winston, co-author of the book "Green to Gold.""You could say you want everyone to source wood from certain kinds of sources, but there may not be enough supply of certain higher quality environmental products," he said.Fleming said the push will result in more higher quality products at a lower cost.But Winston said it is not yet clear how Wal-Mart or others will make the choice to stock green products if they cost more than similar ones that get a lower green rating."It's easy to say at the same quality and price we will choose the sustainable one," he said . But experts said it must win support from rivals for the index to gain widespread acceptance and avoid burdening vendors with competing standards that would raise their cost of business."If this is going to be cost effective and meaningful, (suppliers) can't have a different standard for every retailer out there," said Peter Capozucca, consumer business leader of Deloitte's Enterprise Sustainability group.GRABBING THE NEXT GENERATIONFleming said his vision for an eco-label may be not be seen for five to ten years."There are a lot of consumers that intellectually understand what we're doing, but they can't pay more or it's not enough for them to make a decision on a product," Fleming said. "Our desire is for this to be a global standard."The initiative is ambitious. Wal-Mart, the biggest retailer by revenue, has the cash to launch the index.